Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and health study

Journal of the National Cancer Institute

Volumn 99, Issue 10, 2007, Pages 754-764

  Lawson, Karla A ^a,b,f   Wright, Margaret E ^b   Subar, Amy ^c   Mouw, Traci ^b   Hollenbeck, Albert ^d,e   Schatzkin, Arthur ^a   Leitzmann, Michael F ^b  

^a Division of Cancer Prevention   (United States)

^b Division of Cancer Epidemiology and Genetics   (United States)

^c Cancer Control and Population Sciences   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AACR   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CALCIUM; FOLIC ACID; IRON; LINOLENIC ACID; MULTIVITAMIN; RETINOL; SELENIUM; TRACE ELEMENT; ZINC; VITAMIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; FAMILY HISTORY; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DIET SUPPLEMENTATION; MIDDLE AGED; MULTICENTER STUDY; PROSTATE TUMOR; RISK FACTOR; UNITED STATES;

AGED; COHORT STUDIES; DIETARY SUPPLEMENTS; HUMANS; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; UNITED STATES; VITAMINS;

EID: 34447261186     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk177     Document Type: Article

References (40)

1. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: Data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004;160:339-49.
2. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med 2001;161:805-10.
3. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 2002;162:1472-6.
4. Lee IM. Antioxidant vitamins in the prevention of cancer. Proc Assoc Am Physicians 1999;111:10-5.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA Cancer J Clin 2006;56:106-30.
6. Patterson RE, White E, Kristal AP, Neuhouser ML, Potter JD. Vitamin supplements and cancer risk: The epidemiologic evidence. Cancer Causes Control 1997;8:786-802.
7. Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:887-92.
8. Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr. Multivitamin use and mortality in a large prospective study. Am J Epidemiol 2000;152:149-62.
9. Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005;116:182-6.
10. Stevens VL, McCullough ML, Diver WR, Rodriguez C, Jacobs EJ, Thun MJ, et al. Use of multivitamin and prostate cancer mortality in a large cohort of US men. Cancer Causes Control 2005;16:643-50.
11. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25.
12. Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manage 2005;32:70-5.
13. Fleming ID, Cooper JS, Hensen DE, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia (PA): Lippincott-Raven; 1998.
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume II: the design and analysis of cohort studies. IARC Sci Publ 1987;82:61-4.
15. Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, et al. Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 2000;152:279-86.
16. Tippett KS, Cypel YS, eds. Design and operation: Continuing survey of food intakes by individuals and the diet and health knowledge survey, 1994-96. (1998) (US Department of Agriculture, Beltsville, MD) (Agricultural Research Service Report no. L990332).
17. Platz EA, De Marzo AM, Giovannucci E. Prostate cancer association studies: Pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem 2004;91:553-71.
18. Patterson RE, Neuhouser ML, White E, Hunt JR, Kristal AR. Cancer-related behavior of vitamin supplement users. Cancer Epidemiol Biomarkers Prev 1998;7:79-81.
19. Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006;98:245-54.
20. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
21. Lee IM, Gaziano JM, Buring JE. Vitamin E in the prevention of prostate cancer: Where are we today? J Natl Cancer Inst 2006;98:225-7.
22. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev 1999;8(Pt 1):277-82.
23. National Academy of Science. Selenium. In Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington (DC): National Academy Press; 2000. p. 284-324.
24. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study. Int J Cancer 2005;113:819-24.
25. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI. Diet and prostate cancer: a case-control study. Eur J Cancer 1997;33:101-7.
26. Stevens VL, Rodriguez C, Pavluck AL, McCullough AM, Thun MJ, Calle EE. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006;163:989-96.
27. Archer SL, Stamler J, Moag-Stahlberg A, Van Horn L, Garside D, Chan Q, et al. Association of dietary supplement use with specific micronutrient intakes among middle-aged American men and women: The INTERMAP study. J Am Diet Assoc 2005;105:1106-14.
28. Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, et al. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU Int 2004;93:955-60.
29. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35.
30. Omenn GS, Goodman GE, Thomquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
31. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 2002;155:1023-32.
32. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
33. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003; 157:335-44.
34. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003;95:1004-7.
35. Krone CA, Wyse EJ, Ely JT. Cadmium in zinc-containing mineral supplements. Int J Food Sci Nutr 2001;52:379-82.
36. Bourgoin BP, Boomer D, Powell MJ, Willie S, Edgar D, Evans D. Instrumental comparison for the determination of cadmium and lead in calcium supplements and other calcium-rich matrices. Analyst 1992;117:19-22.
37. International Agency for Research on Cancer. Cadmium and cadmium compounds. In: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC Press; 1993. p. 119-237.
38. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II - a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000;10: 125-34.
39. Block G, Sinha R, Gridley G. Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr 1994;59(Suppl):232S-9S.
40. Patterson RE, Kristal AR, Levy L, McLerran D, White E. Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol 1998;148:643-9.